Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/840CD5B48675AE4CA714D62EA62B56E250D5DE9DD6DD684CE7F074A718074E3706F8A2EC88CCA38F708826331DDB1D07http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/840CD5B48675AE4CA714D62EA62B56E250D5DE9DD6DD684CE7F074A718074E3706F8A2EC88CCA38F708826331DDB1D07http://www.w3.org/2000/01/rdf-schema#comment"targeting of BRM in combination with radiotherapy is supposed to improve the therapeutic outcome of lung cancer patients harboring BRG1 mutations.The present study shows that the moderate radioresponsiveness of NSCLC cells with BRG1 mutations can be increased upon BRM depletion that is associated with a prolonged Rad51-foci prevalence at DNA DSBs."xsd:string
http://purl.uniprot.org/uniprot/#_5E86630477FA8CFE6F33B35439F4856405F0800E8E0EA66CF28992B7D920CAA91F36ABEE80252546CB69BC2DB3E99F70http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/840CD5B48675AE4CA714D62EA62B56E250D5DE9DD6DD684CE7F074A718074E3706F8A2EC88CCA38F708826331DDB1D07
http://purl.uniprot.org/uniprot/Q9HBD4http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/840CD5B48675AE4CA714D62EA62B56E250D5DE9DD6DD684CE7F074A718074E3706F8A2EC88CCA38F708826331DDB1D07
http://purl.uniprot.org/uniprot/#_Q9HBD4-mappedCitation-30478150http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/840CD5B48675AE4CA714D62EA62B56E250D5DE9DD6DD684CE7F074A718074E3706F8A2EC88CCA38F708826331DDB1D07